BDSI - BioDelivery Sciences International, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
81,630
55,640
61,985
15,546
48,231
Cost of Revenue
16,777
15,783
19,496
11,258
8,101
Gross Profit
64,853
39,857
42,489
4,288
40,130
Operating Expenses
Research Development
1,565
4,903
13,040
18,878
20,624
Selling General and Administrative
70,020
58,602
58,869
49,345
54,685
Total Operating Expenses
71,585
63,505
71,909
68,223
75,309
Operating Income or Loss
-6,732
-23,648
-29,420
-63,935
-35,179
Interest Expense
21,660
10,192
-
-
-
Total Other Income/Expenses Net
0
-14
27,310
64
25
Income Before Tax
-28,392
-33,854
-10,687
-67,138
-37,672
Income Tax Expense
-41
13
-15,972
-
-
Income from Continuing Operations
-28,351
-33,867
5,285
-67,138
-37,672
Net Income
-28,351
-33,867
5,285
-67,138
-37,672
Net Income available to common shareholders
-40,851
-46,367
5,285
-67,138
-37,672
Reported EPS
Basic
-
-0.73
0.10
-1.25
-0.72
Diluted
-
-0.73
0.09
-1.25
-0.72
Weighted average shares outstanding
Basic
-
63,165
55,356
53,679
52,385
Diluted
-
63,165
56,402
53,679
52,385
EBITDA
-
-17,765
-23,302
-62,527
-33,880